Omadacycline Completed Phase 3 Trials for Community-Acquired Infections / Pneumonia, Bacterial Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02531438Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)